Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

TOCA

Tocagen (TOCA)

Tocagen Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:TOCA
日付受信時刻ニュースソース見出しコード企業名
2017/10/2722 : 15PR Newswire (US)Tocagen Presents Updated Durable Complete Response Data from Phase 1 Trial of Toca 511 & Toca FC in Recurrent High-Grade Glio...NASDAQ:TOCATocagen Inc
2017/10/2705 : 05PR Newswire (US)Tocagen to Accelerate Toca 511 & Toca FC Development into Pivotal Phase 3 TrialNASDAQ:TOCATocagen Inc
2017/10/1721 : 00PR Newswire (US)Tocagen to Present Updated Durable Response Data from Phase 1 Trial of Toca 511 & Toca FC in Recurrent Brain Cancer at the 20...NASDAQ:TOCATocagen Inc
2017/08/1006 : 19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TOCATocagen Inc
2017/08/1006 : 07PR Newswire (US)Tocagen Reports Second Quarter 2017 Financial and Business ResultsNASDAQ:TOCATocagen Inc
2017/08/1005 : 12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TOCATocagen Inc
2017/08/0305 : 05PR Newswire (US)Tocagen to Report Second Quarter 2017 Financial Results on Wednesday, August 9NASDAQ:TOCATocagen Inc
2017/07/2421 : 00PR Newswire (US)Tocagen Receives European Medicines Agency Priority Medicines (PRIME) Designation for Toca 511 in High Grade GliomaNASDAQ:TOCATocagen Inc
2017/06/1921 : 00PR Newswire (US)Complementary Preclinical Studies Published in Neuro-Oncology Demonstrate Immune Activation Mechanism of Tocagen's Toca 511 &...NASDAQ:TOCATocagen Inc
2017/06/0205 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TOCATocagen Inc
2017/05/2406 : 18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TOCATocagen Inc
2017/05/2405 : 19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TOCATocagen Inc
2017/05/2405 : 05PR Newswire (US)Tocagen Reports First Quarter 2017 Financial and Business ResultsNASDAQ:TOCATocagen Inc
2017/05/1305 : 08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TOCATocagen Inc
2017/05/1121 : 00PR Newswire (US)Tocagen Presents Data at the American Society of Gene and Cell Therapy 20th Annual MeetingNASDAQ:TOCATocagen Inc
2017/05/1102 : 31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TOCATocagen Inc
2017/05/0202 : 51Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:TOCATocagen Inc
2017/04/2519 : 04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TOCATocagen Inc
2017/04/2206 : 45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TOCATocagen Inc
2017/04/2206 : 44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TOCATocagen Inc
2017/04/2206 : 42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TOCATocagen Inc
2017/04/2206 : 40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TOCATocagen Inc
2017/04/2206 : 39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TOCATocagen Inc
2017/04/2206 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TOCATocagen Inc
2017/04/2206 : 29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TOCATocagen Inc
2017/04/2206 : 16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TOCATocagen Inc
2017/04/2005 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TOCATocagen Inc
2017/04/2005 : 05PR Newswire (US)Tocagen Announces Closing of Initial Public Offering and Exercise of the Underwriters' OptionNASDAQ:TOCATocagen Inc
2017/04/1807 : 24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TOCATocagen Inc
2017/04/1406 : 20Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:TOCATocagen Inc
 Showing the most relevant articles for your search:NASDAQ:TOCA